There being so many questions whether science is doing something for people who experience hair loss both male and female, it is important to note that different contenders have done their research to come up with different therapies to cure people with Androgenetic Alopecia.
Histogen, Follica, Trichoscience, Aderans and Oxford BioLabs are the main companies on the fight against Androgenetic Alopecia. We will analyze each company and what they have been able to achieve so far.
Histogen has finally published their 12 month Phase I/II results. They have been able to evaluate a bioengineered human cell-derived formulation known as the Hair Stimulating Complex (HSC). Thanks to their 2013 research, they have been able to maintain the quiescent state of hair follicle stem cell proliferation with cells grown on beads in hypoxic bioreactors. They have hypothised the injection of this medium leading to an increase in the thickness of the hairs and a reversal of the miniaturization process. We hope this turns out well and HSC will simply be used in your most problematic areas to give you that extra boost in hair density.
Follica, a U.S.-based firm, says they are very close to unleashing the product that will finally draw the curtains on the dreaded hair loss. According to their 2013 science report, they claim their proprietary procedure consistently creates new hair follicles in both men and women. In his press release, Dr. William Ju said that Follica has now developed a technology platform suited to support clinical translation of the new findings. After all these years, they have finally promised to prop up the male ego.
TrichoScience is now owned by RepliCel, a regenerative medicine company focused on developing cell therapies that treat functional cellular deficits including chronic tendinosis, pattern baldness and skin aging. The company has planned for the 2014 initiation of Phase 2 trials on the RCT-01 treatment for Achilles tendinosis and RCH-01 treatment for pattern baldness. The company is also developing a unique programmable cell injector device for dermal injection and they hope this will stand out. They are also expected to release their product in 2014.
Aderans is attempting to come up with a real hair cloning technology. The Ji Game process has been tested and has been seen to remove hair follicle cells from a patient’s neck and multiply new cells. The company is now in its Phase II clinical trials across North America.
Oxford BioLabs’s treatment tackles hair loss by stimulating potassium ion channels within hair follicles. The company’s flagship product, TRX2™ Molecular Supplement Capsules, has established itself as a viable alternative to pharmaceuticals and has become one of Europe’s best-selling hair loss supplements. Oxford BioLabs is currently working towards expanding the TRX2 platform technology to other products.
So far those are the latest updates in the clinical process, but we will always update you on what’s happening through our posts and articles on hair loss treatments.